Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > LABS investors...be not "impatient". Look at our investment
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(731)
•••
Comment by proneon Apr 05, 2022 8:34am
117 Views
Post# 34575935

RE:LABS investors...be not "impatient". Look at our investment

RE:LABS investors...be not "impatient". Look at our investmentSurge is coming ....

---->
By Chris Cioffi
Posted April 1, 2022 at 2:34pm

The House passed a bill to legalize marijuana for the second consecutive Congress, signaling a continued interest by Democrats in overhauling the federal approach to a substance that is legal for medical use in 37 states.

The 220-204 vote on the bill, which would decriminalize the possession and use of marijuana, fell mostly along party lines Friday. Three Republicans voted in favor of the bill, and two Democrats voted against. 

When a similar bill passed in 2020, the GOP-controlled Senate declined to take it up, but lawmakers are hopeful that growing public support and a Democratic majority in the chamber could spur action. 

“The Senate works with its own schedule,” said Rep. Earl Blumenauer, an Oregon Democrat. “We’ve talked to a number of people in terms of their support for this, but I’ve only been here 20 years, and I do not pretend to understand the ways of the Senate.”


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities